Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)

ClinicalTrials.gov ID: NCT07400653

Public ClinicalTrials.gov record NCT07400653. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 8:19 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

EVALUATING THE EFFICACY AND SAFETY OF MET097, A FULLY-BIASED ULTRA LONG-ACTING GLP-1RA, IN PEOPLE WITH OVERWEIGHT OR OBESITY AND TYPE 2 DIABETES: A PHASE 3, MULTI-CENTER RANDOMIZED PLACEBO-CONTROLLED TRIAL (VESPER-5)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this clinical study is to learn about the safety and effects of the study medicine to help adults with obesity or overweight and type 2 diabetes lose weight. Being overweight or obese means carrying too much body weight. Type 2 diabetes is a condition where there is too much sugar in the blood. The study medicine is given by a shot under the skin in the belly area. The participants will be trained to do this at home once every week. About 660 out of 1000 adults will also receive the study medicine and about 330 out of 1000 adults will receive placebo. A placebo does not have any medicine in it but looks just like the medicine being studied. The investigators will compare the experiences of people receiving the study medicine to those of the people who do not. This will help us assess if the study medicine is safe and effective. People will take part in this study for about 21 months. During this time, they will have about 14 study visits at the site and 5 over the phone.

Study identification

NCT ID
NCT07400653
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
1,078 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 24, 2026 (Actual)
Primary completion
Oct 12, 2027 (Estimated)
Completion
May 16, 2028 (Estimated)
Last update posted
Oct 13, 2026

2026 – 2028

United States locations

U.S. sites
55
U.S. states
14
U.S. cities
48
Facility City State ZIP Site status
CenExel Anaheim Clinical Trials Anaheim California 92801 —
Alliance Research Institute Canoga Park California 91304 —
Core Healthcare Group Cerritos California 90703 —
Retina Consultants of Orange County Fullerton California 92835 —
CenExel CNS - Collaborative Neuroscience Research Los Alamitos California 90720 —
DexaFit Los Alamitos Los Alamitos California 90720 —
Retina Consultants of Orange County Los Alamitos California 90720 —
Catalina Research Institute, LLC Montclair California 91763 —
Cure Clinical Research Orange California 92866 —
Rolling Oaks Radiology -Palms Oxnard California 93036 —
Clinical Innovations, Inc dba CITrials Riverside California 92506 —
Lundquist Institute for Biomedical Innovation at Harbor- UCLA Medical Center Torrance California 90502 —
Access Eye Institute Westlake Village California 91361 —
CenExcel Rocky Mountain Clinical Research, LLC Englewood Colorado 80113 —
CenExel Denver CO (Rocky Mountain Clinical Research) Englewood Colorado 80113 —
Neuro-Sight Vision Care Lakewood Colorado 80226 —
AMR Clinical Fort Myers Florida 33912 —
Pedro P. Ylisastigui, MD Fort Myers Florida 33912 —
Private Practice Adjacent to For Eyes Optical Hialeah Florida 33014 —
Miami Eye Institute Hollywood Florida 33024 —
Research Centers of America Hollywood Florida 33024 —
Future Medical Research (Civia Health) Longwood Florida 32750 —
Advanced Clinical Research Miami Florida 33156 —
Indago Research & Health Center, Inc Miami Lakes Florida 33016 —
Optimal Research Sites, LLC Orange City Florida 32763 —
Oviedo Medical Research Oviedo Florida 32765 —
CenExel FCR - ForCare Clinical Research Tampa Florida 33613 —
DelRicht Research Atlanta Georgia 30329 —
CenExel iResearch, LLC Decatur Georgia 30030 —
CenExel iResearch, LLC Savannah Georgia 31405 —
Patient First Clinical Trials (PFCTRIALS) Lutherville Maryland 21093 —
DelRicht Research Springfield Missouri 65807 —
Upgrade Performance Institute Elkhorn Nebraska 68022 —
Quality Clinical Research Inc Omaha Nebraska 68114 —
Eye Consultants PC Omaha Nebraska 68124 —
Primary clinical Research Papillion Nebraska 68046 —
Hassman Research Institute Marlton New Jersey 08053 —
Forum Health_Cary (Civia) Cary North Carolina 27511 —
Eximia EquiHealth Research Durham North Carolina 27704 —
Sahana Optometry PLLC dba Family Eye Wellness Holly Springs North Carolina 27540 —
Burke Primary Care Morganton North Carolina 28655 —
Eximia Research - NC, LLC Raleigh North Carolina 27607 —
Tribe Clinical Research LLC.- Greenville Greenville South Carolina 29607 —
Tribe Clinical Research LLC. - Spartanburg Spartanburg South Carolina 29301 —
Civia Health Goodlettsville Goodlettsville Tennessee 37072 —
Civia Health Nashville La Vergne Tennessee 37086 —
Amarillo Medical Specialists LLP Amarillo Texas 79124 —
Forum Austin (Civia Health) Austin Texas 78578 —
GLRI El Paso Research El Paso Texas 79936 —
Cardiovascular Specialists of Willowbrook Houston Texas 77070 —
Dallas Clinical Research Center (Pillar Clinical Research) Richardson Texas 75080 —
Pantheon Clinical Research Bountiful Utah 84010 —
CenExel Salt Lake City UT (JBR Clinical Research) Salt Lake City Utah 84107 —
Murray Vision Center PC Salt Lake City Utah 84107 —
ERA Health Research Redmond Washington 98052 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 125 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07400653, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 13, 2026 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07400653 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →